Pomanda estimates the enterprise value of SIMPLY MEDS PRO LTD at £206.4k based on a Turnover of £478.5k and 0.43x industry multiple (adjusted for size and gross margin).
simply meds pro ltdEstimated Valuation
£98.2k
Pomanda estimates the enterprise value of SIMPLY MEDS PRO LTD at £98.2k based on an EBITDA of £24.5k and a 4.01x industry multiple (adjusted for size and gross margin).
simply meds pro ltdEstimated Valuation
£0
Pomanda estimates the enterprise value of SIMPLY MEDS PRO LTD at £0 based on Net Assets of £-326.4k and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Simply Meds Pro LtdOverview
Simply Meds Pro Ltd is a live company located in hornchurch, RM12 6AA with a Companies House number of 11470749. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in July 2018, it's largest shareholder is
saranjit singh sihra
with a 50% stake. Simply Meds Pro Ltd is a young,
micro sized company, Pomanda has estimated its turnover at
£478.5k with
declining
growth in recent years.
Pomanda's financial health check has awarded Simply Meds Pro Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating2out of 5
2 Strong
2 Regular
6 Weak
Size
annual sales of £478.5k, make it smaller than the average company (£25.3m)
£478.5k - Simply Meds Pro Ltd
£25.3m - Industry AVG
Growth
3 year (CAGR) sales growth of -20%, show it is growing at a slower rate (5.4%)
-20% - Simply Meds Pro Ltd
5.4% - Industry AVG
Production
with a gross margin of 28.2%, this company has a comparable cost of product (28.2%)
28.2% - Simply Meds Pro Ltd
28.2% - Industry AVG
Profitability
an operating margin of 5.1% make it more profitable than the average company (3.8%)
5.1% - Simply Meds Pro Ltd
3.8% - Industry AVG
Employees
with 2 employees, this is below the industry average (36)
2 - Simply Meds Pro Ltd
36 - Industry AVG
Pay Structure
on an average salary of £79.2k, the company has an equivalent pay structure (£79.2k)
£79.2k - Simply Meds Pro Ltd
£79.2k - Industry AVG
Efficiency
resulting in sales per employee of £239.2k, this is less efficient (£643.4k)
£239.2k - Simply Meds Pro Ltd
£643.4k - Industry AVG
Debtor Days
it gets paid by customers after 2 days, this is earlier than average (57 days)
2 days - Simply Meds Pro Ltd
57 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Simply Meds Pro Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Simply Meds Pro Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 2 weeks, this is less cash available to meet short term requirements (11 weeks)
2 weeks - Simply Meds Pro Ltd
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2205.4%, this is a higher level of debt than the average (52.4%)
2205.4% - Simply Meds Pro Ltd
52.4% - Industry AVG
SIMPLY MEDS PRO LTD financials
EXPORT
Simply Meds Pro Ltd's latest turnover from July 2024 is estimated at £478.5 thousand and the company has net assets of -£326.4 thousand. According to their latest financial statements, Simply Meds Pro Ltd has 2 employees and maintains cash reserves of £12.9 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jul 2024
Jul 2023
Jul 2022
Jul 2021
Jul 2020
Jul 2019
Turnover
478,475
3,376,316
1,156,205
922,311
962,791
449,257
Other Income Or Grants
Cost Of Sales
343,789
2,470,525
852,588
691,789
704,677
329,682
Gross Profit
134,687
905,791
303,617
230,522
258,114
119,575
Admin Expenses
110,183
1,061,755
423,632
228,618
252,527
152,592
Operating Profit
24,504
-155,964
-120,015
1,904
5,587
-33,017
Interest Payable
17,834
16,291
6,715
4,907
3,010
136
Interest Receivable
970
751
57
4
3
6
Pre-Tax Profit
7,640
-171,504
-126,673
-2,999
2,580
-33,147
Tax
-1,910
-490
Profit After Tax
5,730
-171,504
-126,673
-2,999
2,090
-33,147
Dividends Paid
Retained Profit
5,730
-171,504
-126,673
-2,999
2,090
-33,147
Employee Costs
158,372
384,870
347,230
264,139
361,130
184,016
Number Of Employees
2
5
5
4
6
3
EBITDA*
24,504
-155,964
-117,615
2,761
6,730
-32,589
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jul 2024
Jul 2023
Jul 2022
Jul 2021
Jul 2020
Jul 2019
Tangible Assets
11,553
2,572
3,429
4,572
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
11,553
2,572
3,429
4,572
Stock & work in progress
27,061
50,024
44,894
32,860
Trade Debtors
2,645
88,600
93,205
49,317
15,837
Group Debtors
Misc Debtors
12,557
34,136
100
8,409
3,072
Cash
12,858
24,089
5,932
3,220
4,475
1,696
misc current assets
8
total current assets
15,503
36,654
155,729
146,549
107,095
53,465
total assets
15,503
36,654
167,282
149,121
110,524
58,037
Bank overdraft
10,234
36,063
64,922
19,117
22,244
4,032
Bank loan
Trade Creditors
133,012
71,244
36,471
14,607
Group/Directors Accounts
6,174
other short term finances
120,000
120,000
25,000
7,410
14,940
hp & lease commitments
other current liabilities
202,032
191,608
75,879
45,616
10,356
66,271
total current liabilities
332,266
347,671
298,813
143,387
84,011
91,084
loans
9,640
21,116
29,098
39,690
57,470
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
9,640
21,116
29,098
39,690
57,470
total liabilities
341,906
368,787
327,911
183,077
141,481
91,084
net assets
-326,403
-332,133
-160,629
-33,956
-30,957
-33,047
total shareholders funds
-326,403
-332,133
-160,629
-33,956
-30,957
-33,047
Jul 2024
Jul 2023
Jul 2022
Jul 2021
Jul 2020
Jul 2019
Operating Activities
Operating Profit
24,504
-155,964
-120,015
1,904
5,587
-33,017
Depreciation
2,400
857
1,143
428
Amortisation
Tax
-1,910
-490
Stock
-27,061
-22,963
5,130
12,034
32,860
Debtors
-9,912
-110,179
29,431
35,579
38,817
18,909
Creditors
-133,012
61,768
34,773
21,864
14,607
Accruals and Deferred Income
10,424
115,729
30,263
35,260
-55,915
66,271
Deferred Taxes & Provisions
Cash flow from operations
42,930
-36,007
-32,052
32,085
-78,662
-3,480
Investing Activities
capital expenditure
11,553
-11,381
-5,000
Change in Investments
cash flow from investments
11,553
-11,381
-5,000
Financing Activities
Bank loans
Group/Directors Accounts
-6,174
6,174
Other Short Term Loans
95,000
17,590
-7,530
14,940
Long term loans
-11,476
-7,982
-10,592
-17,780
57,470
Hire Purchase and Lease Commitments
other long term liabilities
share issue
100
interest
-16,864
-15,540
-6,658
-4,903
-3,007
-130
cash flow from financing
-28,340
71,478
340
-30,213
63,229
6,144
cash and cash equivalents
cash
-11,231
18,157
2,712
-1,255
2,779
1,696
overdraft
-25,829
-28,859
45,805
-3,127
18,212
4,032
change in cash
14,598
47,016
-43,093
1,872
-15,433
-2,336
simply meds pro ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for simply meds pro ltd. Get real-time insights into simply meds pro ltd's credit score, group structure and payment trends.
Perform a competitor analysis for simply meds pro ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other micro companies, companies in RM12 area or any other competitors across 12 key performance metrics.
simply meds pro ltd Ownership
SIMPLY MEDS PRO LTD group structure
Simply Meds Pro Ltd has no subsidiary companies.
Ultimate parent company
SIMPLY MEDS PRO LTD
11470749
SIMPLY MEDS PRO LTD Shareholders
The largest shareholders in Simply Meds Pro Ltd include Saranjit Singh Sihra and Parvinder Singh Sagoo.
saranjit singh sihra
50%
parvinder singh sagoo
50%
simply meds pro ltd directors
Simply Meds Pro Ltd currently has 2 directors.
The longest serving directors include
Mr Parvinder Sagoo (Jul 2018) and
Mr Saranjit Sihra (Jul 2018).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to simply meds pro ltd.
simply meds pro ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SIMPLY MEDS PRO LTD. This can take several minutes, an email will notify you when this has completed.
simply meds pro ltdCompanies House Filings - See Documents
